Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.09.2020 | Case report

Teicoplanin/vancomycin

Hypersensitivity syndrome following allergic cross reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Shao JM, et al. [Teicoplanin-induced hypersensitivity syndrome in a diabetic foot patient with malignant ulcer]. [Chinese]. Zhonghua Shao Shang Za Zhi 36: 747-750, No. 8, 20 Aug 2020 [Chinese; summarised from a translation] Shao JM, et al. [Teicoplanin-induced hypersensitivity syndrome in a diabetic foot patient with malignant ulcer]. [Chinese]. Zhonghua Shao Shang Za Zhi 36: 747-750, No. 8, 20 Aug 2020 [Chinese; summarised from a translation]
Metadaten
Titel
Teicoplanin/vancomycin
Hypersensitivity syndrome following allergic cross reaction: case report
Publikationsdatum
01.09.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-83616-z

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Pantoprazole

Case report

Acitretin